---
figid: PMC5618570__ijms-18-01921-g001
figlink: /pmc/articles/PMC5618570/figure/ijms-18-01921-f001/
number: Figure 1
caption: 'The insulin/insulin-like growth factor (IGF) system. The ligands (insulin,
  IGF1 and IGF2) bind to their specific receptors triggering downstream signaling
  pathways (RAS/MEK/ERK and PI3K/AKT1/mTORC1) through IRS proteins, with the exception
  of IGFR2 that does not transduce signaling. The IGFBPs negatively modulate both
  IGF1 and IGF2. The activation of RAS/MEK/ERK pathway has been shown to be involved
  in the upregulation of MGAT5 gene, increasing the levels of expression of β1,6-branched
  N-glycans. On the contrary, the activation of PI3K/AKT/mTOR signaling cascade was
  associated with the impairment of GnT-III-mediated bisecting GlcNAc N-glycans expression.
  These signaling pathways have an impact on cell growth, survival and invasion, which
  favors tumour development and progression. GnT-III: N-acetylglucosaminyltransferase
  III; GnT-V: N-acetylglucosaminyltransferase V. GnT-III catalyzes the bisecting GlcNAc
  N-glycan structure and GnT-V catalyzes the β1,6 GlcNAc branched N-glycans.'
pmcid: PMC5618570
papertitle: 'Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer
  Progression.'
reftext: Julio Cesar M. de-Freitas-Junior, et al. Int J Mol Sci. 2017 Sep;18(9):1921.
pmc_ranked_result_index: '10401'
pathway_score: 0.9453615
filename: ijms-18-01921-g001.jpg
figtitle: Insulin/insulin-like growth factor (IGF) system
year: '2017'
organisms: Homo sapiens
ndex: 8abdf657-deea-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5618570__ijms-18-01921-g001.html
  '@type': Dataset
  description: 'The insulin/insulin-like growth factor (IGF) system. The ligands (insulin,
    IGF1 and IGF2) bind to their specific receptors triggering downstream signaling
    pathways (RAS/MEK/ERK and PI3K/AKT1/mTORC1) through IRS proteins, with the exception
    of IGFR2 that does not transduce signaling. The IGFBPs negatively modulate both
    IGF1 and IGF2. The activation of RAS/MEK/ERK pathway has been shown to be involved
    in the upregulation of MGAT5 gene, increasing the levels of expression of β1,6-branched
    N-glycans. On the contrary, the activation of PI3K/AKT/mTOR signaling cascade
    was associated with the impairment of GnT-III-mediated bisecting GlcNAc N-glycans
    expression. These signaling pathways have an impact on cell growth, survival and
    invasion, which favors tumour development and progression. GnT-III: N-acetylglucosaminyltransferase
    III; GnT-V: N-acetylglucosaminyltransferase V. GnT-III catalyzes the bisecting
    GlcNAc N-glycan structure and GnT-V catalyzes the β1,6 GlcNAc branched N-glycans.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - PIK3R5
  - PIK3R4
  - AGFG1
  - IRS1
  - IRS4
  - MGAT2
  - PIK3R6
  - RPTOR
  - MAP2K1
  - MAPK3
  - IGF2R
  - IGF2
  - PIK3CD
  - PIK3CA
  - NRAS
  - IRS2
  - MTOR
  - PIK3CG
  - IGF1R
  - MAPK1
  - MAP2K2
  - AKT1
  - PIK3CB
  - KRAS
  - HRAS
  - PIK3R3
  - Cancer
genes:
- word: IGF1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: HR-B
  symbol: HRB
  source: hgnc_prev_symbol
  hgnc_symbol: AGFG1
  entrez: '3267'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: GnT-II
  symbol: GNT-II
  source: hgnc_alias_symbol
  hgnc_symbol: MGAT2
  entrez: '4247'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: IGF2R
  symbol: IGF2R
  source: hgnc_symbol
  hgnc_symbol: IGF2R
  entrez: '3482'
- word: IGF2
  symbol: IGF2
  source: hgnc_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT1
  symbol: AKT1
  source: hgnc_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
